SPARC and neoplasm: SPARC decreases type IV collagen levels and increases the expression of matrix metalloproteins (MMPs) that break down ECM components, thus modulating the tumor microenvironment and promoting tumor growth, invasion, metastasis, and angiogenesis [14,15,16,17].